Latest news with #CloroxCompany
Yahoo
30-07-2025
- Business
- Yahoo
Clorox Increases Quarterly Dividend to $1.24 Per Share
OAKLAND, Calif., July 30, 2025 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared an increase to its quarterly dividend from $1.22 to $1.24 per share on the company's common stock. The dividend is payable August 29, 2025, to shareholders of record as of the close of business on August 13, 2025. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate sustainability into its business reporting. In 2025 the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year. Visit to learn more. Media Investor Relationsinvestorrelations@ CLX-C View original content to download multimedia: SOURCE The Clorox Company Sign in to access your portfolio
Yahoo
26-06-2025
- Business
- Yahoo
Is Clorox's International Expansion Key to Its Long-Term Success?
The Clorox Company's CLX international expansion is a critical lever for its long-term success, especially as growth in its mature domestic markets slows. Currently, international sales account for a relatively small portion of the company's total revenues, nearly 16%, highlighting significant untapped potential abroad. CLX is focusing more on scaling its presence in high-growth emerging markets, like Latin America and Asia, where rising middle-class populations and evolving hygiene habits align well with its core product succeed internationally, Clorox must balance brand recognition with pricing power, invest in localized product innovation and adapt to varied regulatory environments. Currency fluctuations, supply chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global international sales declined 15% year over year in third-quarter fiscal 2025, mainly due to the impacts of the Argentina divestiture. However, excluding the impact of Argentina and a 3-point headwind from foreign exchange rates, the international segment posted organic sales growth of 2%, supported by a 1% increase in organic volume. We expect CLX's international segment's organic sales to increase 15% in the fourth quarter and 8.2% in fiscal ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams, reduce dependence on U.S. performance and unlock higher growth margins. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value. As Clorox accelerates its international expansion, competitors like The Procter & Gamble Company PG, Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD are stepping up efforts to protect their global footholds and stay ahead in the race for & Gamble places a strong emphasis on enhancing its global footprint. The company's largest international markets are Greater China, the United Kingdom, Japan, Canada and Germany, and collectively contributed roughly 20% of its net sales in fiscal 2024. The company looks to strengthen its presence across the global markets by higher investments in localized marketing, constant product and brand innovations, strategic pricing, premiumization and distribution quite a significant portion of revenues from outside the United States, Colgate has a vast international presence with operations in more than 200 countries and territories. The company particularly targets high-growth emerging markets comprising Latin America, Asia and Africa, focusing on localized products and solid brand-building efforts. Colgate remains on track to introduce more global brands, premiumization and innovations to cater to the evolving consumer landscape and boost its global & Dwight continues to strengthen its market position through a robust brand portfolio, strategic pricing and innovation. Its International division was strong in the first quarter of 2025, with organic sales growing 5.8%, buoyed by higher volumes. Net sales rose 2.7%, reflecting broad-based growth across all the international subsidiaries. Key brands such as HERO, THERABREATH and WATERPIK led the performance, underscoring their global appeal and market strength. Church & Dwight is expanding globally by capitalizing on the momentum of its high-growth brands and tailoring marketing to regional demands. Shares of Clorox have lost 26.3% year to date compared with the industry's decline of 1.8%. Image Source: Zacks Investment Research From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 17.80X compared with the industry's average of 20.37X. Image Source: Zacks Investment Research The Zacks Consensus Estimate for CLX's fiscal 2025 earnings implies year-over-year growth of 14.9%, while that of fiscal 2026 shows a decline of 5.3%. The company's EPS estimate for fiscal 2025 and 2026 has been stable in the past 30 days. Image Source: Zacks Investment Research Clorox stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG) : Free Stock Analysis Report Colgate-Palmolive Company (CL) : Free Stock Analysis Report The Clorox Company (CLX) : Free Stock Analysis Report Church & Dwight Co., Inc. (CHD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
26-06-2025
- Business
- Globe and Mail
Is Clorox's International Expansion Key to Its Long-Term Success?
The Clorox Company 's CLX international expansion is a critical lever for its long-term success, especially as growth in its mature domestic markets slows. Currently, international sales account for a relatively small portion of the company's total revenues, nearly 16%, highlighting significant untapped potential abroad. CLX is focusing more on scaling its presence in high-growth emerging markets, like Latin America and Asia, where rising middle-class populations and evolving hygiene habits align well with its core product categories. To succeed internationally, Clorox must balance brand recognition with pricing power, invest in localized product innovation and adapt to varied regulatory environments. Currency fluctuations, supply chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global markets. CLX's international sales declined 15% year over year in third-quarter fiscal 2025, mainly due to the impacts of the Argentina divestiture. However, excluding the impact of Argentina and a 3-point headwind from foreign exchange rates, the international segment posted organic sales growth of 2%, supported by a 1% increase in organic volume. We expect CLX's international segment's organic sales to increase 15% in the fourth quarter and 8.2% in fiscal 2025. Looking ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams, reduce dependence on U.S. performance and unlock higher growth margins. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value. CLX's International Push: How PG, CL & CHD Vie to Stay Ahead As Clorox accelerates its international expansion, competitors like The Procter & Gamble Company PG, Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD are stepping up efforts to protect their global footholds and stay ahead in the race for dominance. Procter & Gamble places a strong emphasis on enhancing its global footprint. The company's largest international markets are Greater China, the United Kingdom, Japan, Canada and Germany, and collectively contributed roughly 20% of its net sales in fiscal 2024. The company looks to strengthen its presence across the global markets by higher investments in localized marketing, constant product and brand innovations, strategic pricing, premiumization and distribution partnerships. Generating quite a significant portion of revenues from outside the United States, Colgate has a vast international presence with operations in more than 200 countries and territories. The company particularly targets high-growth emerging markets comprising Latin America, Asia and Africa, focusing on localized products and solid brand-building efforts. Colgate remains on track to introduce more global brands, premiumization and innovations to cater to the evolving consumer landscape and boost its global foothold. Church & Dwight continues to strengthen its market position through a robust brand portfolio, strategic pricing and innovation. Its International division was strong in the first quarter of 2025, with organic sales growing 5.8%, buoyed by higher volumes. Net sales rose 2.7%, reflecting broad-based growth across all the international subsidiaries. Key brands such as HERO, THERABREATH and WATERPIK led the performance, underscoring their global appeal and market strength. Church & Dwight is expanding globally by capitalizing on the momentum of its high-growth brands and tailoring marketing to regional demands. CLX's Price Performance, Valuation & Estimates Shares of Clorox have lost 26.3% year to date compared with the industry 's decline of 1.8%. From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 17.80X compared with the industry's average of 20.37X. The Zacks Consensus Estimate for CLX's fiscal 2025 earnings implies year-over-year growth of 14.9%, while that of fiscal 2026 shows a decline of 5.3%. The company's EPS estimate for fiscal 2025 and 2026 has been stable in the past 30 days. Clorox stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG): Free Stock Analysis Report Colgate-Palmolive Company (CL): Free Stock Analysis Report The Clorox Company (CLX): Free Stock Analysis Report Church & Dwight Co., Inc. (CHD): Free Stock Analysis Report
Yahoo
21-06-2025
- Business
- Yahoo
Clorox Stock: Is CLX Underperforming the Consumer Staples Sector?
Valued at a market cap of $14.9 billion, The Clorox Company (CLX) manufactures and markets consumer and professional products. The Oakland, California-based company's offerings span cleaning and disinfecting products, bags and wraps, grilling supplies, natural personal care, food dressings, and water-filtration systems. Companies valued at $10 billion or more are typically classified as 'large-cap stocks,' and Clorox fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the household & personal products industry. The company's strengths lie in its diverse and well-recognized brand portfolio, including Clorox, Brita, Burt's Bees, Glad, and Kingsford among others, with many of its products holding leading market shares in their categories. Its broad distribution network, spanning mass retailers, grocery chains, e-commerce platforms, and professional channels, ensures wide market reach both domestically and internationally. 2 Outstanding Stocks Under $50 to Buy and Hold Now 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! This household & personal care products company has dipped 29.4% from its 52-week high of $171.37, reached on Dec. 6, 2024. Moreover, shares of CLX have declined 16.5% over the past three months, considerably lagging behind the Consumer Staples Select Sector SPDR Fund's (XLP) marginal uptick during the same time frame. In the longer term, CLX has fallen 12.8% over the past 52 weeks, underperforming XLP's 3.4% rise over the same time frame. Moreover, on a YTD basis, shares of Clorox are down 25.5%, compared to XLP's 2.3% return. To confirm its bearish trend, CLX has been trading below its 200-day moving average since early February, with minor fluctuations, and has remained below its 50-day moving average since mid-December, 2024. On May 5, Clorox released weaker-than-expected Q3 results, prompting its share price to fall 2.4% in the following trading session. A consumption slowdown across most of its reportable segments, along with the divestitures of its VMS and Argentina operations, led to an 8% year-over-year decline in its overall revenue to $1.7 billion, which fell short of the consensus estimates by 2.3%. Moreover, its adjusted EPS of $1.45 dropped 15.2% from the year-ago quarter and missed Wall Street expectations by 7.6%. However, despite a challenging and volatile consumer and geopolitical environment, Clorox achieved a 240 basis-point expansion in gross margin, driven by cost-saving initiatives and benefits from divestitures. Moreover, its adjusted EBIT improved 2.3% from the same period last year to $266 million. Looking ahead to fiscal 2025, CLX updated its outlook, now expecting net sales to be down 1% to flat, and adjusted EPS in the range of $6.95 to $7.35. Clorox's underperformance looks pronounced when compared to its rival, Kimberly-Clark Corporation (KMB), which declined 9.7% over the past 52 weeks and 2.4% on a YTD basis. Looking at CLX's recent underperformance, analysts remain cautious about its prospects. The stock has a consensus rating of "Hold' from the 18 analysts covering it, and the mean price target of $142.75 suggests an 18% premium to its current price levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-06-2025
- Business
- Yahoo
Clorox's Innovation Strategy Elevates Everyday Essentials
Innovation sits at the core of The Clorox Company's CLX strategy to remain competitive in a category dominated by global giants and cost-effective private labels. It focuses on consumer-centric innovation, wherein improvements in performance, sensory appeal and convenience are key levers. In third-quarter 2025, Clorox highlighted the success of several premium products such as Scentiva disinfecting sprays, the upgraded ToiletWand and odor-control litter, all designed to command a premium while meeting real, evolving consumer needs. This strategy aligns with the company's belief that consumers are still willing to pay more for products that deliver superior value per approach to innovation is both bifurcated and realistic. On one hand, the company is leaning into premiumization across categories to differentiate from private label. On the other hand, it is expanding price-pack architecture to provide budget-conscious consumers with flexible options, such as smaller entry-price packs and value sizes for club and mass channels. Clorox has been disciplined in its promotional strategy, choosing to support innovation through targeted marketing and selective discounting rather than broad-based price cuts. This dual approach allows the company to protect margins while defending its share across income segments and competitive ahead, Clorox remains committed to investing in R&D, supported by tools like its digital transformation and upcoming ERP system upgrade, which will enable more agile innovation and supply chain responsiveness. Despite current market headwinds and volatility in consumer spending, the company sees innovation as a key driver of long-term growth and margin expansion. Clorox's track record of delivering trustworthy, high-performing products in essential categories uniquely positions it to win in both up and down cycles, provided the company continues to innovate where it matters most to consumers. The Procter & Gamble Company PG, Colgate-Palmolive Company CL and Church & Dwight Co., Inc. CHD are the key consumer staple companies competing with Clorox in the global & Gamble uses a smart strategy when it comes to innovation. The company keeps improving its popular brands like Tide, Febreze and Mr. Clean by adding new features, better scents or easier packaging. At the same time, PG gives shoppers different choices depending on their focuses on value-driven innovation, especially in home care and personal hygiene. The company regularly updates products with new scents, improved cleaning formulas and convenient packaging. Colgate also invests in sustainability, such as recyclable bottles and concentrated products. Its innovation is often designed to meet the needs of both budget-conscious and environmentally aware & Dwight is a key competitor to Clorox, known for its value-focused and niche household brands like OxiClean and Arm & Hammer. The company emphasizes cost-effective innovation, often targeting specific consumer needs with affordable, functional products. CHD competes directly with Clorox in laundry additives, cleaning sprays, and baking soda-based solutions. Clorox shares have lost 25.5% year to date compared with the industry's growth of 2.2%. Image Source: Zacks Investment Research From a valuation standpoint, CLX trades at a forward price-to-earnings ratio of 18.0X, significantly below the industry's average of 20.23X. Image Source: Zacks Investment Research The Zacks Consensus Estimate for CLX's 2025 earnings implies year-over-year growth of 14.9%, whereas its 2026 earnings estimate suggests a year-over-year decline of 5.4%. The estimates for 2025 and 2026 have been unchanged in the past 30 days. Image Source: Zacks Investment Research CLX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Procter & Gamble Company (The) (PG) : Free Stock Analysis Report Colgate-Palmolive Company (CL) : Free Stock Analysis Report The Clorox Company (CLX) : Free Stock Analysis Report Church & Dwight Co., Inc. (CHD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
